Journals / Güncel Pediatri / 2012 / Cilt: 10 - Sayı: 3

The role of fecal calprotectin in investigating pediatric ulcerative colitis

Çocuklarda ülseratif kolit tanısının belirlenmesinde fekal kalprotektinin rolü

Pages
80–84
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FCP values of the UC and control groups were 398.4 μg/gr stool (56.7-2450) and 19.4 μg/gr stool (2-81), respectively (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In tro duc ti on: Fecal calprotectin (FCP) can be found in high concentrations in inflammatory bowel disease due to the increase in leucocyte turnover in intestinal wall or increase of migration of neutrophils into the lumen.
📊
Key Findings & Data:Materials and Methods: A total of 19 patients with UC (10 females, 9 males, age: 11.5±3.5 years old) whoose stool samples collected during the diagnosis period and 20 healthy controls (10 female, 10 male, age: 10.3±4.5 years old) were included in the study.
💡
Conclusion & Impact:FCP values of the UC and control groups were 398.4 μg/gr stool (56.7-2450) and 19.4 μg/gr stool (2-81), respectively (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In tro duc ti on: Fecal calprotectin (FCP) can be found in high concentrations in inflammatory bowel disease due to the increase in leucocyte turnover in intestinal wall or increase of migration of neutrophils into the lumen. In this study, we aimed to determine the FCP values of the ulcerative colitis (UC) patients at the time of diagnosis and to investigate the applicability and effectiveness of this non-invasive method in the diagnosis of the disease, routinely. Materials and Methods: A total of 19 patients with UC (10 females, 9 males, age: 11.5±3.5 years old) whoose stool samples collected during the diagnosis period and 20 healthy controls (10 female, 10 male, age: 10.3±4.5 years old) were included in the study. Stool samples were collected for FCP analysis by ELISA method at the time of diagnosis and before the treatment period. Results: FCP values of the UC group were statistically higher than the control group. FCP values of the UC and control groups were 398.4 μg/gr stool (56.7-2450) and 19.4 μg/gr stool (2-81), respectively (p

Özet

Girifl: Dışkıda fekal kalprotektin (FKP) inflamatuvar bağırsak hastalıklarında (İBH), bağırsak duvarındaki lökositlerin döngüsünün ve bağırsak lümeni içerisine nötrofillerin migrasyonunun artmasıyla yüksek konsantrasyonlarda bulunabilmektedir. Çalışmamızda ülseratif kolitli (ÜK) hastalarımızda tanı anında FKP değerlerini belirlemeyi ve noninvazif bir yöntem olan bu testin rutin uygulanabilirliğinin etkinliği amaçlanmıştır. Gereç ve Yöntem: Çalışmamıza tanı konulduğu sırada dışkı örnekleri alınmış olan 19 ÜKli (10 kız, 9 erkek, yaş ort: 11,5±3,5 yıl) ve 20 sağlıklı kontrol (10 kız, 10 erkek, yaş ort: 10,3±4,5 yıl) dahil edildi. Hastalarımızdan tanı konulduktan hemen sonra, tedavi öncesi, dışkı örnekleri ELİSA yöntemi ile FKP çalışılması için toplandı. Bulgular: ÜK grubunun tamamında FKP değerleri kontrol grubundan anlamlı derecede yüksekti. Dışkıda saptamış olduğumuz FKP değerleri ÜK ve kontrol grubumuzda sırasıyla 398,4 (56,7-2450) μg/gr dışkı ve 19,4 (2-81) μg/gr dışkı olarak bulundu (p

🔖

Cite This Article

SERDAR, M., SEMİZEL, E., KARACA, Y., MERT, E. Y., KOCAEFE, H., KASIRGA, H. E., ÜNAL, F., Ömür, E. Ç. (2022). The role of fecal calprotectin in investigating pediatric ulcerative colitis. Güncel Pediatri, Cilt: 10 - Sayı: 3, 80–84. https://ajindex.com/articles/528014

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Erbayrak M, Turkay C, Eraslan E, Çetinkaya H, Kasapoğlu B, Bektaş M. The role of fecal calprotectin in investigating inflamatory bowel diseases. Clinics (Sao Paulo) 2009;64:421-5
  2. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical charecteristics of children with newly diagnosed inflamatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525-31
  3. Gisbert JP, Bermejo F, Perez-Calle JL, Taxonera C, Vera I, McNicholl AG, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009;15:1190-8
  4. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition; Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, Dubinsky MC, et al. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. J Pediatr Gastroenterol Nutr 2007;44:653-74
  5. Mack DR, Langton C, Markowitz J, LeLeiko N, Griffiths A, Bousvaros A, et al. Laboratory values for children with newly diagnosed inflamatory bowel disease. Pediatrics 2007;119: 1113-9
  6. Uslu N, Baysoy G, Balamtekin N, Hızal G, Demir H, Saltık- Temizel İN, ve ark. Çocuklarda enflamatuar bağırsak hastalığı tanısında noninvasif bir belirteç: fekal kalprotektin. Çocuk Sağlığı ve Hastalıkları Dergisi 2011;54:22-7
  7. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: Useful magic or unnecessary toys. Gut 2006;55:426-31
  8. Fagerhol MK, Dale I, Andersson T. Release and quantitation of a lycocyte derived protein (L1). Scand J Heamatol 1980;24:393-8
  9. Ertekin V, Selimoğlu MA, Turgut A, Bakan N. Fecal calprotectin concetrationin celiac disease. J Clin Gastroenterol 2010;44:544-6
  10. Johne B, Kronborg O, Ton HI, Kristinsson J, Fuglerud P. A new fecal calprotectin test for colorectal neoplasia. Cinical results and comparison with previous method. Scand J Gastroenterol 2001;36:291-6
  11. Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6
  12. Carroccio A, Iacono G, Cottone M, Prima LD, Cartabellotta F, Cavataio F, et al. Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bow